LymphedemaV1, Main, Exploration, bibRecord, 005377

Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry

Identifieur interne : 005377 ( Main/Exploration ); précédent : 005376; suivant : 005378

Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry

Auteurs : Kari Thompson [États-Unis] ; Julia Grabowski [États-Unis] ; Sidney L. Saltzstein [États-Unis] ; Georgia R. Sadler [États-Unis] ; Sarah L. Blair [États-Unis]

Source :

The Breast Journal [ 1075-122X ] ; 2011-09.

RBID : ISTEX:717C807DBC17FB2075F5B94602C9B4C0B729BC5F

Abstract

Abstract: Adenoid cystic carcinoma (ACC) is an uncommon type of breast cancer. There are limited data about its epidemiology, tumor characteristics, and outcomes. Using a large, population‐based data base, this study aimed to identify specific characteristics of patients with adenoid cystic breast cancer, investigate its natural history, and determine its long‐term prognosis. The California Cancer Registry, a population‐based registry, was reviewed from the years 1988 to 2006. The data were analyzed with relation to patient age, tumor size and stage, and overall survival. Relative cumulative actuarial survival was determined using the Berkson‐Gage life table method. A total of 244 cases of invasive adenoid cystic cancer were identified in women during this time period. The patients’ median age was 61.9 years. Most cases were diagnosed in non‐Hispanic White women (82%, n = 200), followed by African American (6%, n = 15), Asian/Pacific‐Islander (5.7%, n = 14) and Hispanic women (4.4%, n = 12). The remainder of the patients was of unknown or other ethnicity. Tumors were between 1 and 140 mm in size. At the time of diagnosis, 92% (n = 225) of patients had localized disease, 5% (n = 12) of patients had regional disease, and even fewer (n = 7) had either distant or unknown staged disease. Lymph node involvement was not present in any tumors smaller than 1.4 cm. The relative cumulative survival of patients with adenoid cystic breast carcinoma was 95.6% at 5 years and 94.9% at 10 years. ACC of the breast is a rare disease with an overall good prognosis. Knowing that this cancer usually presents as localized disease, with lymph node involvement seen only with larger tumors, can help clinicians plan the operative management of these tumors.

Url:

DOI: 10.1111/j.1524-4741.2011.01117.x

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry</title>
<author><name sortKey="Thompson, Kari" sort="Thompson, Kari" uniqKey="Thompson K" first="Kari" last="Thompson">Kari Thompson</name>
</author>
<author><name sortKey="Grabowski, Julia" sort="Grabowski, Julia" uniqKey="Grabowski J" first="Julia" last="Grabowski">Julia Grabowski</name>
</author>
<author><name sortKey="Saltzstein, Sidney L" sort="Saltzstein, Sidney L" uniqKey="Saltzstein S" first="Sidney L." last="Saltzstein">Sidney L. Saltzstein</name>
</author>
<author><name sortKey="Sadler, Georgia R" sort="Sadler, Georgia R" uniqKey="Sadler G" first="Georgia R." last="Sadler">Georgia R. Sadler</name>
</author>
<author><name sortKey="Blair, Sarah L" sort="Blair, Sarah L" uniqKey="Blair S" first="Sarah L." last="Blair">Sarah L. Blair</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:717C807DBC17FB2075F5B94602C9B4C0B729BC5F</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.1524-4741.2011.01117.x</idno>
<idno type="url">https://api.istex.fr/document/717C807DBC17FB2075F5B94602C9B4C0B729BC5F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003502</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003502</idno>
<idno type="wicri:Area/Istex/Curation">003502</idno>
<idno type="wicri:Area/Istex/Checkpoint">000809</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000809</idno>
<idno type="wicri:doubleKey">1075-122X:2011:Thompson K:adenoid:cystic:breast</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721506</idno>
<idno type="RBID">PMC:3721506</idno>
<idno type="wicri:Area/Pmc/Corpus">003A28</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003A28</idno>
<idno type="wicri:Area/Pmc/Curation">003A27</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003A27</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003113</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003113</idno>
<idno type="wicri:Area/Ncbi/Merge">004556</idno>
<idno type="wicri:Area/Ncbi/Curation">004556</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004556</idno>
<idno type="wicri:doubleKey">1075-122X:2011:Thompson K:adenoid:cystic:breast</idno>
<idno type="wicri:Area/Main/Merge">005416</idno>
<idno type="wicri:Area/Main/Curation">005377</idno>
<idno type="wicri:Area/Main/Exploration">005377</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry</title>
<author><name sortKey="Thompson, Kari" sort="Thompson, Kari" uniqKey="Thompson K" first="Kari" last="Thompson">Kari Thompson</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Surgery, UCSD, School of Medicine, La Jolla</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Rebecca and John Moores UCSD Cancer Center, UCSD, La Jolla</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Grabowski, Julia" sort="Grabowski, Julia" uniqKey="Grabowski J" first="Julia" last="Grabowski">Julia Grabowski</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Surgery, UCSD, School of Medicine, La Jolla</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Rebecca and John Moores UCSD Cancer Center, UCSD, La Jolla</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Saltzstein, Sidney L" sort="Saltzstein, Sidney L" uniqKey="Saltzstein S" first="Sidney L." last="Saltzstein">Sidney L. Saltzstein</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Rebecca and John Moores UCSD Cancer Center, UCSD, La Jolla</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Family and Preventive Medicine (Epidemiology), UCSD School of Medicine, La Jolla</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sadler, Georgia R" sort="Sadler, Georgia R" uniqKey="Sadler G" first="Georgia R." last="Sadler">Georgia R. Sadler</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Surgery, UCSD, School of Medicine, La Jolla</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Rebecca and John Moores UCSD Cancer Center, UCSD, La Jolla</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Blair, Sarah L" sort="Blair, Sarah L" uniqKey="Blair S" first="Sarah L." last="Blair">Sarah L. Blair</name>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Surgery, UCSD, School of Medicine, La Jolla</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Rebecca and John Moores UCSD Cancer Center, UCSD, La Jolla</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">The Breast Journal</title>
<title level="j" type="alt">BREAST JOURNAL</title>
<idno type="ISSN">1075-122X</idno>
<idno type="eISSN">1524-4741</idno>
<imprint><biblScope unit="vol">17</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="485">485</biblScope>
<biblScope unit="page" to="489">489</biblScope>
<biblScope unit="page-count">5</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2011-09">2011-09</date>
</imprint>
<idno type="ISSN">1075-122X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1075-122X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Abstract:  Adenoid cystic carcinoma (ACC) is an uncommon type of breast cancer. There are limited data about its epidemiology, tumor characteristics, and outcomes. Using a large, population‐based data base, this study aimed to identify specific characteristics of patients with adenoid cystic breast cancer, investigate its natural history, and determine its long‐term prognosis. The California Cancer Registry, a population‐based registry, was reviewed from the years 1988 to 2006. The data were analyzed with relation to patient age, tumor size and stage, and overall survival. Relative cumulative actuarial survival was determined using the Berkson‐Gage life table method. A total of 244 cases of invasive adenoid cystic cancer were identified in women during this time period. The patients’ median age was 61.9 years. Most cases were diagnosed in non‐Hispanic White women (82%, n = 200), followed by African American (6%, n = 15), Asian/Pacific‐Islander (5.7%, n = 14) and Hispanic women (4.4%, n = 12). The remainder of the patients was of unknown or other ethnicity. Tumors were between 1 and 140 mm in size. At the time of diagnosis, 92% (n = 225) of patients had localized disease, 5% (n = 12) of patients had regional disease, and even fewer (n = 7) had either distant or unknown staged disease. Lymph node involvement was not present in any tumors smaller than 1.4 cm. The relative cumulative survival of patients with adenoid cystic breast carcinoma was 95.6% at 5 years and 94.9% at 10 years. ACC of the breast is a rare disease with an overall good prognosis. Knowing that this cancer usually presents as localized disease, with lymph node involvement seen only with larger tumors, can help clinicians plan the operative management of these tumors.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Thompson, Kari" sort="Thompson, Kari" uniqKey="Thompson K" first="Kari" last="Thompson">Kari Thompson</name>
</region>
<name sortKey="Blair, Sarah L" sort="Blair, Sarah L" uniqKey="Blair S" first="Sarah L." last="Blair">Sarah L. Blair</name>
<name sortKey="Blair, Sarah L" sort="Blair, Sarah L" uniqKey="Blair S" first="Sarah L." last="Blair">Sarah L. Blair</name>
<name sortKey="Grabowski, Julia" sort="Grabowski, Julia" uniqKey="Grabowski J" first="Julia" last="Grabowski">Julia Grabowski</name>
<name sortKey="Grabowski, Julia" sort="Grabowski, Julia" uniqKey="Grabowski J" first="Julia" last="Grabowski">Julia Grabowski</name>
<name sortKey="Sadler, Georgia R" sort="Sadler, Georgia R" uniqKey="Sadler G" first="Georgia R." last="Sadler">Georgia R. Sadler</name>
<name sortKey="Sadler, Georgia R" sort="Sadler, Georgia R" uniqKey="Sadler G" first="Georgia R." last="Sadler">Georgia R. Sadler</name>
<name sortKey="Saltzstein, Sidney L" sort="Saltzstein, Sidney L" uniqKey="Saltzstein S" first="Sidney L." last="Saltzstein">Sidney L. Saltzstein</name>
<name sortKey="Saltzstein, Sidney L" sort="Saltzstein, Sidney L" uniqKey="Saltzstein S" first="Sidney L." last="Saltzstein">Sidney L. Saltzstein</name>
<name sortKey="Thompson, Kari" sort="Thompson, Kari" uniqKey="Thompson K" first="Kari" last="Thompson">Kari Thompson</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005377 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005377 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:717C807DBC17FB2075F5B94602C9B4C0B729BC5F
   |texte=   Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry

Adenoid Cystic Breast Carcinoma: Is Axillary Staging Necessary in All Cases? Results from the California Cancer Registry

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.